Pseudo-continuous arterial spin labeling imaging of cerebral blood perfusion asymmetry in drug-naïve patients with first-episode major depression
Guangdong Chen, Haiman Bian, Deguo Jiang, Mingwei Cui, Shengzhang Ji, Mei Liu, Xu Lang, Chuanjun Zhuo, Guangdong Chen, Haiman Bian, Deguo Jiang, Mingwei Cui, Shengzhang Ji, Mei Liu, Xu Lang, Chuanjun Zhuo
Abstract
Many previous studies have reported that regional cerebral blood flow (rCBF) aberrations may be one of the pathological characteristics of depression and rCBF has demonstrated a certain degree of asymmetry. However, studies investigating the cerebral blood perfusion asymmetry changes of drug-naïve patients experiencing their first episode of major depression using pseudo-continuous arterial spin labeling (pCASL) are rare. Ten drug-naïve patients experiencing their first major depression episode and 15 healthy volunteers were enrolled in the current study. A novel pCASL method was applied to whole brain MRI scans of all of the samples. The Statistics Parameter Mapping and Relative Expression Software Tool software packages were used for the pre-processing and statistical analysis of the two sets of images, and the differences in the cerebral blood perfusion at the whole brain level were compared between the two groups. Compared with the healthy control group, the cerebral perfusion of the depression patients showed an asymmetric pattern. Decreased cerebral blood perfusion regions were primarily located in the left hemisphere, specifically in the left temporal lobe, frontal lobe and cingulate cortex [P<0.05 and cluster size ≥30 with false discovery rate (FDR) correction]. Simultaneously, increased perfusion regions were predominantly located in the right hemisphere, specifically in the right cerebellum, thalamus, frontal lobe and anterior cingulate cortex (P<0.05 and cluster size ≥30, with FDR correction). Thus, pCASL may characterize the alterations in cerebral blood perfusion of patients with depression.
Keywords: asymmetry; drug naïve; first-episode; functional magnetic resonance imaging; magnetic resonance imaging; major depression; pseudo continuous arterial spin labeling; pseudo-continuous arterial spin labeling; regional cerebral blood flow; regional cerebral flow.
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5228216/bin/br-05-06-0675-g00.jpg)
Figure 2.
Images displayed in layers for…
Figure 2.
Images displayed in layers for the brain regions with increased perfusion in patients…
- Resting cerebral blood flow alterations specific to the comitant exophoria patients revealed by arterial spin labeling perfusion magnetic resonance imaging.Huang X, Zhou S, Su T, Ye L, Zhu PW, Shi WQ, Min YL, Yuan Q, Yang QC, Zhou FQ, Shao Y. Huang X, et al. Microvasc Res. 2018 Nov;120:67-73. doi: 10.1016/j.mvr.2018.06.007. Epub 2018 Jul 2. Microvasc Res. 2018. PMID: 29991447
- Characteristic distributions of regional cerebral blood flow changes in major depressive disorder patients: a pseudo-continuous arterial spin labeling (pCASL) study.Ota M, Noda T, Sato N, Hattori K, Teraishi T, Hori H, Nagashima A, Shimoji K, Higuchi T, Kunugi H. Ota M, et al. J Affect Disord. 2014 Aug;165:59-63. doi: 10.1016/j.jad.2014.04.032. Epub 2014 Apr 21. J Affect Disord. 2014. PMID: 24882178
- Measurement of brain perfusion in newborns: pulsed arterial spin labeling (PASL) versus pseudo-continuous arterial spin labeling (pCASL).Boudes E, Gilbert G, Leppert IR, Tan X, Pike GB, Saint-Martin C, Wintermark P. Boudes E, et al. Neuroimage Clin. 2014 Aug 30;6:126-33. doi: 10.1016/j.nicl.2014.08.010. eCollection 2014. Neuroimage Clin. 2014. PMID: 25379424 Free PMC article.
- Pseudo-continuous arterial spin labeling MRI study of schizophrenic patients.Ota M, Ishikawa M, Sato N, Okazaki M, Maikusa N, Hori H, Hattori K, Teraishi T, Ito K, Kunugi H. Ota M, et al. Schizophr Res. 2014 Apr;154(1-3):113-8. doi: 10.1016/j.schres.2014.01.035. Epub 2014 Feb 26. Schizophr Res. 2014. PMID: 24581548
- Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression.Ho TC, Wu J, Shin DD, Liu TT, Tapert SF, Yang G, Connolly CG, Frank GK, Max JE, Wolkowitz O, Eisendrath S, Hoeft F, Banerjee D, Hood K, Hendren RL, Paulus MP, Simmons AN, Yang TT. Ho TC, et al. J Am Acad Child Adolesc Psychiatry. 2013 Oct;52(10):1076-1091.e2. doi: 10.1016/j.jaac.2013.07.008. Epub 2013 Jul 25. J Am Acad Child Adolesc Psychiatry. 2013. PMID: 24074474 Free PMC article.
- Cerebral blood flow in adolescents with drug-naive, first-episode major depressive disorder: An arterial spin labeling study based on voxel-level whole-brain analysis.Xiong Y, Chen RS, Wang XY, Li X, Dai LQ, Yu RQ. Xiong Y, et al. Front Neurosci. 2022 Jul 27;16:966087. doi: 10.3389/fnins.2022.966087. eCollection 2022. Front Neurosci. 2022. PMID: 35968369 Free PMC article.
- Atrophic Corpus Callosum Associated with Altered Functional Asymmetry in Major Depressive Disorder.Ran S, Zuo Z, Li C, Yin X, Qu W, Tang Q, Wang Y, Shi Y, Li H. Ran S, et al. Neuropsychiatr Dis Treat. 2020 Jun 10;16:1473-1482. doi: 10.2147/NDT.S245078. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32606700 Free PMC article.
- Single and repeated ketamine treatment induces perfusion changes in sensory and limbic networks in major depressive disorder.Sahib AK, Loureiro JRA, Vasavada MM, Kubicki A, Joshi SH, Wang K, Woods RP, Congdon E, Wang DJJ, Boucher ML, Espinoza R, Narr KL. Sahib AK, et al. Eur Neuropsychopharmacol. 2020 Apr;33:89-100. doi: 10.1016/j.euroneuro.2020.01.017. Epub 2020 Feb 12. Eur Neuropsychopharmacol. 2020. PMID: 32061453 Free PMC article.
- Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial.Cooper CM, Chin Fatt CR, Jha M, Fonzo GA, Grannemann BD, Carmody T, Ali A, Aslan S, Almeida JRC, Deckersbach T, Fava M, Kurian BT, McGrath PJ, McInnis M, Parsey RV, Weissman M, Phillips ML, Lu H, Etkin A, Trivedi MH. Cooper CM, et al. EClinicalMedicine. 2019 May 18;10:32-41. doi: 10.1016/j.eclinm.2019.04.007. eCollection 2019 Apr. EClinicalMedicine. 2019. PMID: 31193824 Free PMC article.
- Trajectories in Cerebral Blood Flow Following Antidepressant Treatment in Late-Life Depression: Support for the Vascular Depression Hypothesis.Wei W, Karim HT, Lin C, Mizuno A, Andreescu C, Karp JF, Reynolds CF 3rd, Aizenstein HJ. Wei W, et al. J Clin Psychiatry. 2018 Oct 23;79(6):18m12106. doi: 10.4088/JCP.18m12106. J Clin Psychiatry. 2018. PMID: 30358242 Free PMC article. Clinical Trial.
-
- Ho TC, Wu J, Shin DD, Liu TT, Tapert SF, Yang G, Connolly CG, Frank GK, Max JE, Wolkowitz O, et al. Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression. J Am Acad Child Adolesc Psychiatry. 2013;52:1076–1091.e2. doi: 10.1016/j.jaac.2013.07.008. - DOI - PMC - PubMed
- Full Text Sources
- Other Literature Sources
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5228216/bin/br-05-06-0675-g01.jpg)
References
- Saltiel PF, Silvershein DI. Major depressive disorder: Mechanism-based prescribing for personalized medicine. Neuropsychiatr Dis Treat. 2015;11:875–888.
- Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry. 2000;48:813–829. doi: 10.1016/S0006-3223(00)01020-9.
- Ho TC, Wu J, Shin DD, Liu TT, Tapert SF, Yang G, Connolly CG, Frank GK, Max JE, Wolkowitz O, et al. Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression. J Am Acad Child Adolesc Psychiatry. 2013;52:1076–1091.e2. doi: 10.1016/j.jaac.2013.07.008.
- Wang DJ, Chen Y, Fernández-Seara MA, Detre JA. Potentials and challenges for arterial spin labeling in pharmacological magnetic resonance imaging. J Pharmacol Exp Ther. 2011;337:359–366. doi: 10.1124/jpet.110.172577.
- Hartkamp NS, Petersen ET, De Vis JB, Bokkers RP, Hendrikse J. Mapping of cerebral perfusion territories using territorial arterial spin labeling: Techniques and clinical application. NMR Biomed. 2013;26:901–912. doi: 10.1002/nbm.2836.
- Järnum H, Eskildsen SF, Steffensen EG, Lundbye-Christensen S, Simonsen CW, Thomsen IS, Fründ ET, Théberge J, Larsson EM. Longitudinal MRI study of cortical thickness, perfusion, and metabolite levels in major depressive disorder. Acta Psychiatr Scand. 2011;124:435–446. doi: 10.1111/j.1600-0447.2011.01766.x.
- Ota M, Noda T, Sato N, Hattori K, Teraishi T, Hori H, Nagashima A, Shimoji K, Higuchi T, Kunugi H. Characteristic distributions of regional cerebral blood flow changes in major depressive disorder patients: A pseudo-continuous arterial spin labeling (pCASL) study. J Affect Disord. 2014;165:59–63. doi: 10.1016/j.jad.2014.04.032.
- Nobler MS, Olvet KR, Sackeim HA. Effects of medications on cerebral blood flow in late-life depression. Curr Psychiatry Rep. 2002;4:51–58. doi: 10.1007/s11920-002-0013-x.
- First MB, Spitzer RL, Gibbon M, Williams JB. Biometrics Research. New York State Psychiatric Institute; New York, NY: 1996. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID)
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. doi: 10.1136/jnnp.23.1.56.
- Alexopoulos GS, Kiosses DN, Heo M, Murphy CF, Shanmugham B, Gunning-Dixon F. Executive dysfunction and the course of geriatric depression. Biol Psychiatry. 2005;58:204–210. doi: 10.1016/j.biopsych.2005.04.024.
- Davies J, Lloyd KR, Jones IK, Barnes A, Pilowsky LS. Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression. Am J Psychiatry. 2003;160:374–376. doi: 10.1176/appi.ajp.160.2.374.
- Galynker II, Cai J, Ongseng F, Finestone H, Dutta E, Serseni D. Hypofrontality and negative symptoms in major depressive disorder. J Nucl Med. 1998;39:608–612.
- Wang Y, Zhang H, Tang S, Liu X, O'Neil A, Turner A, Chai F, Chen F, Berk M. Assessing regional cerebral blood flow in depression using 320-slice computed tomography. PLoS One. 2014;9:e107735. doi: 10.1371/journal.pone.0107735.
- Blackhart GC, Minnix JA, Kline JP. Can EEG asymmetry patterns predict future development of anxiety and depression? A preliminary study. Biol Psychol. 2006;72:46–50. doi: 10.1016/j.biopsycho.2005.06.010.
- Bruder GE, Quitkin FM, Stewart JW, Martin C, Voglmaier MM, Harrison WM. Cerebral laterality and depression: Differences in perceptual asymmetry among diagnostic subtypes. J Abnorm Psychol. 1989;98:177–186. doi: 10.1037/0021-843X.98.2.177.
- Hannesdóttir DK, Doxie J, Bell MA, Ollendick TH, Wolfe CD. A longitudinal study of emotion regulation and anxiety in middle childhood: Associations with frontal EEG asymmetry in early childhood. Dev Psychobiol. 2010;52:197–204.
- Kemp AH, Cooper NJ, Hermens G, Gordon E, Bryant R, Williams LM. Toward an integrated profile of emotional intelligence: Introducing a brief measure. J Integr Neurosci. 2005;4:41–61. doi: 10.1142/S0219635205000677.
- Liu H, Yin HF, Wu DX, Xu SJ. Event-related potentials in response to emotional words in patients with major depressive disorder and healthy controls. Neuropsychobiology. 2014;70:36–43. doi: 10.1159/000364829.
- Quraan MA, Protzner AB, Daskalakis ZJ, Giacobbe P, Tang CW, Kennedy SH, Lozano AM, McAndrews MP. EEG power asymmetry and functional connectivity as a marker of treatment effectiveness in DBS surgery for depression. Neuropsychopharmacology. 2014;39:1270–1281. doi: 10.1038/npp.2013.330.
- Sundermann B, Olde Lütke Beverborg M, Pfleiderer B. Toward literature-based feature selection for diagnostic classification: A meta-analysis of resting-state fMRI in depression. Front Hum Neurosci. 2014;8:692. doi: 10.3389/fnhum.2014.00692.
- Moretti DV, Prestia A, Binetti G, Zanetti O, Frisoni GB. Increase of theta frequency is associated with reduction in regional cerebral blood flow only in subjects with mild cognitive impairment with higher upper alpha/low alpha EEG frequency power ratio. Front Behav Neurosci. 2013;7:188. doi: 10.3389/fnbeh.2013.00188.
- Lui S, Parkes LM, Huang X, Zou K, Chan RC, Yang H, Zou L, Li D, Tang H, Zhang T, et al. Depressive disorders: Focally altered cerebral perfusion measured with arterial spin-labeling MR imaging. Radiology. 2009;251:476–484. doi: 10.1148/radiol.2512081548.
- Smith DJ, Cavanagh JT. The use of single photon emission computed tomography in depressive disorders. Nucl Med Commun. 2005;26:197–203. doi: 10.1097/00006231-200503000-00004.
- Vasic N, Wolf ND, Grön G, Sosic-Vasic Z, Connemann BJ, Sambataro F, von Strombeck A, Lang D, Otte S, Dudek M, et al. Baseline brain perfusion and brain structure in patients with major depression: A multimodal magnetic resonance imaging study. J Psychiatry Neurosci. 2015;40:412–421. doi: 10.1503/jpn.140246.
- Patrick KS, Corbin TR, Murphy CE. Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker. J Pharm Sci. 2014;103:3834–3842. doi: 10.1002/jps.24202.
Source: PubMed